By InvitationNot Applicable

An Observational Study of Patients With Chronic Liver Disease

United States500,000 participantsStarted 2024-02-19

Plain-language summary

TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Disease Cohort •Adult\* patients at the time of enrollment with a diagnosis of CLD/cirrhosis by ICD-10 code in the EHR interface Engaged Cohort * Adult\* patients diagnosed and managed for CLD/cirrhosis invited to participate * Ability to provide written informed consent Exclusion Criteria: Disease Cohort * Death * Manual removal (sponsor or site request) * No EHR interface encounter \> 3 years. Engaged Cohort * Patient expressed desire to withdraw consent to complete PROs * Failure to complete PROs within 24 weeks of initial invitation * Greater than 24 months lapse of survey completion after baseline surveys completed * Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort.

What they're measuring

To characterize the natural history of disease in patients with CLD from various etiologies and Cirrhosis

Timeframe: 20 Years

To assess safety and effectiveness of CLD/Cirrhosis treatments and treatments for complications of any chronic liver disease

Timeframe: 20 Years

To establish learning health networks focused on quality of care for patients

Timeframe: 20 Years

Trial details

NCT IDNCT05744713

SponsorTarget PharmaSolutions, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2037-12-31

View on ClinicalTrials.gov More Chronic Liver Disease trials